WST West Pharmaceutical Services, I
$394.73▲ +0.66%
Healthcare
Other
Volume 649.6K
Avg Volume (10D) 506.5K
Key Metrics & Fundamentals
Market Cap
$27.78B
P/E Ratio
50.5
Div Yield
0.26%
52W Range
223.83 - 397.16
% vs 50 MA
8.75%
% vs 200 MA
27.05%
RSI-14
70.5
MACD Histogram
+1.5200
Beta (1Y vs SPY)
0.61
Free Cash Flow
$80.80M
Gross Rev
$872.30M
Gross Profit
$329.20M
EBITDA
$241.20M
COGS
$543.10M
Operating Exp
$137.30M
Operating Income
$191.90M
EBIT
$191.90M
Pretax Income
$180.10M
Net Income
$154.00M
EPS (Diluted)
2.15
Price & Volume History
Loading chart…
Recent News
Laboratory operator Quest reports cyber breach affecting patient records
Reuters · Oct 22, 2026 7:40 AM ET
Reasons to Add West Pharmaceutical Stock to Your Portfolio Now
Zacks · Oct 21, 2026 8:29 AM ET
West Declares Quarterly Dividend
PR Newswire · Oct 19, 2026 6:04 PM ET
3 Low-Volatility Stocks We’re Skeptical Of
StockStory · Oct 19, 2026 5:36 AM ET
West Pharmaceutical Stock Gains 36.1% YTD: What's Behind the Rally?
Zacks · Oct 15, 2026 8:25 AM ET
Veeva Systems' Basics Gains Traction With 175+ Emerging Biotech Firms
Zacks · Oct 13, 2026 10:03 AM ET
TD Cowen Adjusts Price Target on West Pharmaceutical Services to $420 From $410
MT Newswires · Oct 13, 2026 9:27 AM ET
ANGO Q1 Earnings Beat Estimates on Med Tech Growth, Revenues Up Y/Y
Zacks · Oct 9, 2026 9:58 AM ET
Reasons to Hold Veeva Systems Stock in Your Portfolio for Now
Zacks · Oct 9, 2026 9:43 AM ET
Smith+Nephew Launches CARTIHEAL Implant Across Key European Markets
Zacks · Oct 8, 2026 12:18 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See WST's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.